menu
    • menu

    Company profile for Clementia Pharmaceuticals

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are developing palovarotene, an investigational retinoic acid receptor gamma (RARγ) selective agonist, for the treatment of individuals who are affected by fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas (MO) and other diseases. For FOP, we are preparing for a New Drug Application (NDA) for episodic, flare-up based palovarotene treatment, which we intend to submit to the U.S. Food and Drug Administrat...
    We are developing palovarotene, an investigational retinoic acid receptor gamma (RARγ) selective agonist, for the treatment of individuals who are affected by fibrodysplasia ossificans progressiva (FOP), multiple osteochondromas (MO) and other diseases. For FOP, we are preparing for a New Drug Application (NDA) for episodic, flare-up based palovarotene treatment, which we intend to submit to the U.S. Food and Drug Administration (FDA) in the second half of 2019, and subject to approval, a U.S. commercial launch in the first half of 2020.We also completed enrollment in our Phase 3 MOVE Trial in FOP in August 2018.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Clementia PharmaceuticalsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1000 de la Gauchetière O, Suite 1200 Montreal, QC H3B 4W5
    Telephone
    Telephone
    +1 (514) 940-3600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://clementiapharma.com
    Linkedin
    Linkedin
    https://in.linkedin.com/company/clementia-pharmaceuticals-inc-
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/clementiapharma?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ipsen's CBO is on a $3B mission to get the company 'back on the right track'
    Ipsen's CBO is on a $3B mission to get the company 'back on the right track'

    27 Oct 2021

    // Nicole DeFeudis ENDPTS

    https://endpts.com/exclusive-a-year-into-his-role-ipsen-cbo-is-on-a-3b-mission-to-get-the-company-back-on-the-right-track/

    Nicole DeFeudis ENDPTS
    27 Oct 2021
    Share Share
    Ipsen scraps pivotal trial as partial clinical hold drags on
    Ipsen scraps pivotal trial as partial clinical hold drags on

    26 Mar 2020

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ipsen-scraps-pivotal-trial-as-partial-clinical-hold-drags

    Nick Paul Taylor FIERCE BIOTECH
    26 Mar 2020
    Share Share
    Revenue growth at Ipsen numbs pain of palovarotene calamity
    Revenue growth at Ipsen numbs pain of palovarotene calamity

    14 Feb 2020

    // Phil Taylor PMLIVE

    http://www.pmlive.com/pharma_news/revenue_growth_at_ipsen_numbs_pain_of_palovarotene_calamity_1325622

    Phil Taylor PMLIVE
    14 Feb 2020
    Share Share
    Ipsen bags Blueprint drug to move deeper into ultra-rare disease
    Ipsen bags Blueprint drug to move deeper into ultra-rare disease

    16 Oct 2019

    // Nick Paul Taylor FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/ipsen-bags-blueprint-drug-to-move-deeper-into-ultra-rare-disease

    Nick Paul Taylor FIERCE BIOTECH
    16 Oct 2019
    Share Share
    Clementia Pharma Obtains Interim Order for Proposed Transaction With Ipsen
    Clementia Pharma Obtains Interim Order for Proposed Transaction With Ipsen

    07 Mar 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/clementia-pharmaceuticals-inc-obtains-interim-order-for-proposed-transaction-with-ipsen-sa-and-enters-into-support-and-voting-agreements-with-two-additional-significant-shareholders-300808811.html

    PR NEWSWIRE
    07 Mar 2019
    Share Share
    Ipsen buys rare disease group Clementia in $1.3bn deal
    Ipsen buys rare disease group Clementia in $1.3bn deal

    26 Feb 2019

    // PRESS RELEASE

    http://investor.clementiapharma.com/news-releases/news-release-details/ipsen-acquire-clementia-pharmaceuticals-significantly-boost-rare

    PRESS RELEASE
    26 Feb 2019
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search